Page 14 - John Jacobs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novavax said on Thursday it has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over canceled orders that had created financial uncertainty for the U.S. maker of COVID-19 shots. Gavi, an alliance that co-finances vaccine purchases with low-income countries, paid Novavax $700 million over 2021 and 2022 for up to 350 million doses of its COVID vaccine. Novavax, which launched its vaccine after several competitors due to manufacturing and regulatory delays, did not deliver any doses before the contract's d...

Novavax has resolved a potentially expensive battle with Gava, opening up a pathway for the company to get out of the red.

Novavax said it reached a settlement with Gavi related to the 2021 advance purchase agreement for Novavax's prototype COVID-19 vaccine. The agreement brings the pending arbitration related to the advance purchase agreement to a close.

Novavax reaches a settlement related to an advance purchase agreement with Gavi.

Kendalle Alquwaie was joined by supporters in the City Council chambers Monday to agree to submit a plan by March 18 with a timeline for addressing the various deficiencies.